|
|
 |
|
| | |
| | | | |
organism-gene
|
|
PR:Q02383 |
semenogelin-2 (human)
|
hSEMG2
|
"A semenogelin-2 that is encoded in the genome of human." [PRO:DNx, UniProtKB:Q02383]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056838 |
semenogelin-2 N-glycosylated 1 (human)
|
hSEMG2/NGlyco:1
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G00912UN." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056839 |
semenogelin-2 N-glycosylated 2 (human)
|
hSEMG2/NGlyco:2
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G02815KT. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G02815KT." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056840 |
semenogelin-2 N-glycosylated 3 (human)
|
hSEMG2/NGlyco:3
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G05933EN. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G05933EN." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056841 |
semenogelin-2 N-glycosylated 4 (human)
|
hSEMG2/NGlyco:4
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G10339FR. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G10339FR." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056842 |
semenogelin-2 N-glycosylated 5 (human)
|
hSEMG2/NGlyco:5
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G52162PS. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G52162PS." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056843 |
semenogelin-2 N-glycosylated 6 (human)
|
hSEMG2/NGlyco:6
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G60923RB. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G60923RB." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056844 |
semenogelin-2 N-glycosylated 7 (human)
|
hSEMG2/NGlyco:7
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G80475RE. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G80475RE." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056845 |
semenogelin-2 N-glycosylated 8 (human)
|
hSEMG2/NGlyco:8
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G83555HU. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G83555HU." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056846 |
semenogelin-2 N-glycosylated 9 (human)
|
hSEMG2/NGlyco:9
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G87051GH. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G87051GH." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056847 |
semenogelin-2 N-glycosylated 10 (human)
|
hSEMG2/NGlyco:10
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G88374WZ." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000056848 |
semenogelin-2 N-glycosylated 11 (human)
|
hSEMG2/NGlyco:11
|
"A semenogelin-2 (human) that has been N-glycosylated at the residue equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:Q02383-1, in which the glycan composition is represented by GlyTouCan:G92597CK. Example: UniProtKB:Q02383-1, Asn-272, MOD:00160~GNO:G92597CK." [GlyGen:Q02383-1, PMID:26791533, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000083791 |
semenogelin-2 cysteinylated 1 (human)
|
hSEMG2/Cyst:1
|
"A semenogelin-2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-159 of the amino acid sequence represented by UniProtKB:Q02383. UniProtKB:Q02383, Cys-159, MOD:00765." [IEDB_epitope:1588134, PRO:DNx]
|
|
|
|
|
|
